The NIH has put nearly $1 billion into research and development of machine learning and AI medical research since 2019.
Newly published research has found an association between factors like a person's age, biological sex, and history of atrial ...
The results suggest new ways to predict cognitive decline in Alzheimer patients, and that caregivers need to be considered in treatment plans.
Additionally, the Company previously announced that IGC-1C along with IGC-1A have been identified by the Company's Artificial ...
Aging is far more complex than just an advancing clock. It's a tangled web of molecular changes that don’t play by linear ...
Researchers used machine learning to study blood samples from more than 45,000 people.AI tools were able to identify patterns ...
Creators of Glaze and Nightshade copyright protection tools are helping artists fight back against generative AI ...
Predictive analysis has potential applications for many diseases. It will be possible to detect them well before onset and, ...
IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, is reporting on its preclinical research that demonstrates the therapeutic potential of IGC-1C, a novel small-molecule ...
Two phase 3 studies of simufilam in Alzheimer's disease, RETHINK-ALZ and REFOCUS-ALZ, are approaching a readout. A recent ...
Corewell Health and Michigan State University researchers are the first in the state to use de-identified electronic health ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window TTHealthWatch is a weekly podcast from Texas Tech. In it, ...